NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.58
-0.47 (-2.60%)
At close: May 15, 2026, 4:00 PM EDT
17.35
-0.23 (-1.31%)
After-hours: May 15, 2026, 7:27 PM EDT
NovoCure Stock Forecast
Stock Price Forecast
The 7 analysts that cover NovoCure stock have a consensus rating of "Buy" and an average price target of $27.29, which forecasts a 55.23% increase in the stock price over the next year. The lowest target is $17 and the highest is $49.
Price Target: $27.29 (+55.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NovoCure stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 1 | 1 | 1 | 1 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -3.30% | May 4, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +13.77% | May 1, 2026 |
| Wedbush | Wedbush | Hold Reiterates $18 | Hold | Reiterates | $18 | +2.39% | Apr 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $49 | Strong Buy | Maintains | $47 → $49 | +178.73% | Feb 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $47 | Strong Buy | Maintains | $39 → $47 | +167.35% | Feb 12, 2026 |
Financial Forecast
Revenue This Year
715.73M
from 655.35M
Increased by 9.21%
Revenue Next Year
783.18M
from 715.73M
Increased by 9.42%
EPS This Year
-1.70
from -1.22
EPS Next Year
-1.19
from -1.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 745.5M | 836.9M | |||
| Avg | 715.7M | 783.2M | |||
| Low | 678.2M | 731.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 13.8% | 16.9% | |||
| Avg | 9.2% | 9.4% | |||
| Low | 3.5% | 2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.49 | -0.90 | |||
| Avg | -1.70 | -1.19 | |||
| Low | -1.82 | -1.36 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.